| Amount | Holding |
|---|---|
| 3.75% | Karyopharm Therapeutics Inc |
| 3.61% | ACADIA Pharmaceuticals Inc |
| 3.60% | Exact Sciences Corp |
| 2.85% | Immunomedics Inc |
| 2.82% | Insulet Corp |
| 2.79% | Cree Inc |
| 2.36% | Natera Inc |
| 2.28% | Quanta Services Inc |
| 2.26% | Adaptive Biotechnologies Corp |
| 2.10% | Science Applications International Corp |
| 2.01% | Ultra Clean Holdings Inc |
| 1.97% | Alteryx Inc Class A |
| 1.89% | bluebird bio Inc |
| 1.86% | Century Communities Inc |
| 1.85% | Knight-Swift Transportation Holdings Inc A |
| 1.82% | NanoString Technologies Inc |
| 1.74% | Nektar Therapeutics |
| 1.71% | Guidewire Software Inc |
| 1.63% | KBR Inc |
| 1.62% | Ambarella Inc |
| 1.61% | Quanterix Corp |
| 1.53% | Biomarin Pharmaceutical Inc |
| 1.49% | Five Below Inc |
| 1.48% | Medallia Inc |
| 1.41% | Euronav NV |
Expense Ratio Rating
8 /10
Expense Rating
0 /10
Market Score
1 /10
Category Score
5 /10
Market Size
1 /10
$MSSCX Alternatives
29%
FI Score
- msscx
- Mutual Fund
- US Stocks
- Small Growth
AMG Frontier Small Cap Growth Fund Class I
Expenses: 0.96% (Better than 1% of similar funds)
This is a bad choice for a Small Growth US Stocks fund. See why ยป